Company news: Roche, MRM, McKesson

Share this article:
Roche's latest real estate deal is putting the drug maker on both sides of the New York-New Jersey divide. The company announced Thursday that it was establishing a research division in Manhattan, and taking with it some of the responsibilities and 200 employees that were part of the Nutley, NJ site that is set to close, reported the New York Times. The Swiss company is still going to keep 50 management-level jobs in New Jersey, the Times noted.

MRM worldwide also announced a location change Thursday. The digital agency will open the doors to its new Princeton, NJ, office September 24. The move includes an open floor plan “to foster community and creativity,” as well as a collaborative space dubbed Einstein's Attic, which gives clients and creatives space to test out different technologies.

Arizona Attorney General Tom Horne is suing drug wholesaler McKesson over price inflation, reported the Associated Press. The suit accuses the wholesaler of marking up the cost of drugs including Allegra, Celebrex, Coumadin, Flonase, Lipitor and Valium. The lawsuit alleges that the markup was passed along to third-party payers and consumers and seeks civil penalties of up to $10,000 per violation as well as restitution. Kentucky's Attorney General Jack Conway filed a pricing lawsuit against McKesson last year.
Share this article:

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.